Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04590014 · ClinicalTrials.gov registry record · NA
Clinical Efficacy in Relief of Dyspnea by HVNI: Evaluation of New Device Equivalence
A NA study, sponsored by Vapotherm.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT04590014 is a NA study that was terminated before completion, run by Vapotherm. The registered enrollment target is 5 participants.
The verdict
NCT04590014, a NA study, was terminated before completion, sponsored by Vapotherm.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
This study will evaluate the ability of a new High Velocity Nasal Insufflation \[HVNI\] device design to effect ventilation and related physiological responses relative to the current HVNI device design.
Interventions
- DEVICE Conventional Precision Flow
- DEVICE HVNI HVT2.0 Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2022-01-12 |
| Est. Completion | 2022-07-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04590014
The ClinicalTrials.gov registry entry for NCT04590014 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vapotherm, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Conventional Precision Flow is the first listed.
NCT04590014 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04590014 about?
NCT04590014 is a clinical study titled "Clinical Efficacy in Relief of Dyspnea by HVNI: Evaluation of New Device Equivalence". This study will evaluate the ability of a new High Velocity Nasal Insufflation \[HVNI\] device design to effect ventilation and related physiological responses relative to the current HVNI device design.
What is the current status of trial NCT04590014?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2022-01-12. Estimated completion is 2022-07-15.
What interventions are being tested in trial NCT04590014?
The interventions under investigation include: Conventional Precision Flow (DEVICE), HVNI HVT2.0 Device (DEVICE).
Who is sponsoring clinical trial NCT04590014?
This trial is sponsored by Vapotherm, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.